Junxia Wei

Recombinant immunotoxins with albumin-binding domains have long half-lives and high antitumor activity

Junxia Wei, Tapan K. Bera, Xiu Fen Liu et al. · Proceedings of the National Academy of Sciences · 2018 · 56 citations · Full text

Medicine, Oncology, Pharmacology +13

Highly active CAR T cells that bind to a juxtamembrane region of mesothelin and are not blocked by shed mesothelin

Xiufen Liu, Masanori Onda, Nathan Watson et al. · Proceedings of the National Academy of Sciences · 2022 · 49 citations · Full text

Life Sciences, Cell Biology, Immunology +15

Casein nanoparticles as oral delivery carriers of mequindox for the improved bioavailability

Li Chen, Junxia Wei, Mengying An et al. · Colloids and Surfaces B Biointerfaces · 2020 · 44 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +14

Serum anti-AEG-1 auto-antibody is a potential novel biomarker for malignant tumors

Xi Chen, Ke Dong, Long Min et al. · Oncology Letters · 2012 · 35 citations · Full text

Life Sciences, Immunology, Oncology +17

Synthesis of penetrable macroporous silica spheres for high-performance liquid chromatography

Junxia Wei, Zhi‐Guo Shi, Fei Chen et al. · Journal of Chromatography A · 2009 · 32 citations

Natural Sciences, Chemistry, Materials Science +6